| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| P F J Schulte, D van Dijk, D Cohen, J Bogers, B Bakke. Comment on 'effectiveness and safety of rapid clozapine titration in schizophrenia'. Acta psychiatrica Scandinavica. vol 130. issue 1. 2015-02-12. PMID:24689810. |
comment on 'effectiveness and safety of rapid clozapine titration in schizophrenia'. |
2015-02-12 |
2023-08-12 |
Not clear |
| Antonios Paraschaki. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report. Clinical neuropharmacology. vol 37. issue 2. 2015-02-04. PMID:24614672. |
pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report. |
2015-02-04 |
2023-08-12 |
Not clear |
| Antonios Paraschaki. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report. Clinical neuropharmacology. vol 37. issue 2. 2015-02-04. PMID:24614672. |
clozapine is currently considered as the most effective medication for the treatment of refractory schizophrenia. |
2015-02-04 |
2023-08-12 |
Not clear |
| Antonios Paraschaki. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report. Clinical neuropharmacology. vol 37. issue 2. 2015-02-04. PMID:24614672. |
we present a case of a 37-year-old patient with refractory schizophrenia who has responded well to the combination of clozapine, sodium valproate, and pipamperone. |
2015-02-04 |
2023-08-12 |
Not clear |
| Ravi Parekh, Zozik Fattah, Dilraj Sahota, Bernie Colac. Clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia. BMJ case reports. vol 2014. 2015-01-28. PMID:24849641. |
clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia. |
2015-01-28 |
2023-08-13 |
Not clear |
| Ravi Parekh, Zozik Fattah, Dilraj Sahota, Bernie Colac. Clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia. BMJ case reports. vol 2014. 2015-01-28. PMID:24849641. |
we describe the development of tubulointerstitial nephritis after starting clozapine therapy in a patient with treatment-resistant schizophrenia. |
2015-01-28 |
2023-08-13 |
Not clear |
| Ravi Parekh, Zozik Fattah, Dilraj Sahota, Bernie Colac. Clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia. BMJ case reports. vol 2014. 2015-01-28. PMID:24849641. |
a 54-year-old mixed-race patient with a longstanding history of paranoid schizophrenia was started on the antipsychotic clozapine. |
2015-01-28 |
2023-08-13 |
Not clear |
| De-Wei Shang, Li-Jun Li, Xi-Pei Wang, Yu-Guan Wen, Yu-Peng Ren, Wei Guo, Wen-Biao Li, Liang Li, Tian-Yan Zhou, Wei Lu, Chuan-Yue Wan. Population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and PANSS scores in patients with schizophrenia. Therapeutic drug monitoring. vol 36. issue 3. 2015-01-12. PMID:24342896. |
population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and panss scores in patients with schizophrenia. |
2015-01-12 |
2023-08-12 |
Not clear |
| De-Wei Shang, Li-Jun Li, Xi-Pei Wang, Yu-Guan Wen, Yu-Peng Ren, Wei Guo, Wen-Biao Li, Liang Li, Tian-Yan Zhou, Wei Lu, Chuan-Yue Wan. Population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and PANSS scores in patients with schizophrenia. Therapeutic drug monitoring. vol 36. issue 3. 2015-01-12. PMID:24342896. |
the aim of this study was to characterize the relationship between accumulated exposure of clozapine and changes in positive and negative syndrome scale (panss) score in chinese patients with schizophrenia by pharmacokinetic/pharmacodynamic (pk/pd) modeling. |
2015-01-12 |
2023-08-12 |
Not clear |
| Seon-Cheol Park, Myung-Soo Lee, Seung-Gul Kang, Seung-Hwan Le. Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample. Journal of Korean medical science. vol 29. issue 5. 2015-01-10. PMID:24851031. |
in this study, it has been reported substantial prescription rates of first-generation antipsychotics and antipsychotic polypharmacy and relatively small prescription rate of clozapine to patients with schizophrenia. |
2015-01-10 |
2023-08-13 |
Not clear |
| M Gahr, K Rehbaum, B J Conneman. Clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: impact of clozapine serum levels and fluvoxamine add-on. Pharmacopsychiatry. vol 47. issue 3. 2015-01-07. PMID:24846087. |
clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: impact of clozapine serum levels and fluvoxamine add-on. |
2015-01-07 |
2023-08-13 |
Not clear |
| M Gahr, K Rehbaum, B J Conneman. Clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: impact of clozapine serum levels and fluvoxamine add-on. Pharmacopsychiatry. vol 47. issue 3. 2015-01-07. PMID:24846087. |
among antiserotonergic second generation antipsychotics (sga), particularly treatment with clozapine (clz) is associated with the development of second-onset obsessive compulsive symptoms (ocs) in schizophrenia. |
2015-01-07 |
2023-08-13 |
Not clear |
| Amresh Shrivastava, Megan Johnston, Nilesh Shah, Larry Stitt, Shivanshu Shrivastava, Avinash De Sous. Clozapine response and pre-treatment EEG-is there some kind of relationship. Industrial psychiatry journal. vol 23. issue 1. 2014-12-23. PMID:25535440. |
clozapine has been used widely in the management of treatment-resistant schizophrenia. |
2014-12-23 |
2023-08-13 |
Not clear |
| Kara E O'Connell, Jogin Thakore, Kumlesh K De. Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine. Schizophrenia research. vol 156. issue 1. 2014-12-22. PMID:24742875. |
pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine. |
2014-12-22 |
2023-08-13 |
Not clear |
| Raquelle I Mesholam-Gately, Lauren E Gibson, Larry J Seidman, Alan I Gree. Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine. Schizophrenia research. vol 155. issue 1-3. 2014-12-17. PMID:24685823. |
schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine. |
2014-12-17 |
2023-08-12 |
Not clear |
| Maria Rosaria A Muscatello, Antonio Bruno, Pasquale De Fazio, Cristina Segura-Garcia, Gianluca Pandolfo, Rocco Zoccal. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine. Expert opinion on pharmacotherapy. vol 15. issue 16. 2014-12-15. PMID:25284216. |
augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine. |
2014-12-15 |
2023-08-13 |
Not clear |
| Maria Rosaria A Muscatello, Antonio Bruno, Pasquale De Fazio, Cristina Segura-Garcia, Gianluca Pandolfo, Rocco Zoccal. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine. Expert opinion on pharmacotherapy. vol 15. issue 16. 2014-12-15. PMID:25284216. |
although clozapine (clz) is considered the best evidence-based therapeutic option for treatment of resistant schizophrenia patients, a significant proportion of clz-treated patients show a partial or inadequate response to treatment, leading to increased healthcare cost and poor quality of life for affected individuals. |
2014-12-15 |
2023-08-13 |
Not clear |
| Thomas Schnell, Dagmar Koethe, Anna Krasnianski, Stefanie Gairing, Knut Schnell, Jörg Daumann, Euphrosyne Gouzoulis-Mayfran. Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study. The American journal on addictions. vol 23. issue 3. 2014-12-10. PMID:24628830. |
ziprasidone versus clozapine in the treatment of dually diagnosed (dd) patients with schizophrenia and cannabis use disorders: a randomized study. |
2014-12-10 |
2023-08-12 |
Not clear |
| Danielle Gulick, David T Chau, Jibran Y Khokhar, Ree Dawson, Alan I Gree. Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster. Psychiatry research. vol 218. issue 3. 2014-12-10. PMID:24836200. |
the atypical antipsychotic clozapine reduces alcohol drinking in patients with schizophrenia. |
2014-12-10 |
2023-08-13 |
Not clear |
| Jari-Pekka Klemettilä, Olli Kampman, Niko Seppälä, Merja Viikki, Mari Hämäläinen, Eeva Moilanen, Esa Leinone. Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine. Psychiatry research. vol 218. issue 3. 2014-12-10. PMID:24837425. |
cytokine and adipokine alterations in patients with schizophrenia treated with clozapine. |
2014-12-10 |
2023-08-13 |
Not clear |